In vivo, Estrogen exerts its effects by binding to estrogen receptors (ER) present in the tissues surrounding the joints, specifically binding to estrogen receptor beta (ERβ), which negatively regulates arthritis progression by inhibiting the activation of the NF-κB pathway in synoviocytes (188). Here, ESR1 is linked to arthritic joint disease.